Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinoma

Oncology Reports

Volumn 29, Issue 2, 2013, Pages 685-689

  Kinoshita, Hiroki ^a   Okabe, Hirohisa ^a   Beppu, Toru ^a   Chikamoto, Akira ^a   Hayashi, Hiromitsu ^a   Imai, Katsunori ^a   Mima, Kosuke ^a   Nakagawa, Shigeki ^a   Ishimoto, Takatsugu ^a   Miyake, Keisuke ^a   Yokoyama, Naomi ^a   Ishiko, Takatoshi ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Cystine glutamic acid transporter; Hepatocellular carcinoma; Reactive oxygen species

Indexed keywords

CYSTINE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; MESSENGER RNA;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; OXIDATION REDUCTION STATE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

AGED; AMINO ACID TRANSPORT SYSTEM Y+; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; HEP G2 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; LIVER NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84872800192     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2162     Document Type: Article

References (25)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics. CA Cancer J Clin 62: 10-29, 2012.
2. Carr BI: Hepatocellular carcinoma: current management and future trends. Gastroenterology 127 (Suppl 1): S218-S224, 2004. (Pubitemid 39423390)
3. Kassahun WT, Fangmann J, Harms J, et al: Liver resection and transplantation in the management of hepatocellular carcinoma: a review. Exp Clin Transplant 4: 549-558, 2006. (Pubitemid 46443886)
4. Griffith OW: Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 27: 922-935, 1999. (Pubitemid 29507466)
5. Chung WJ, Lyons SA, Nelson GM, et al: Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci 25: 7101-7110, 2005. (Pubitemid 41113926)
6. Doxsee DW, Gout PW, Kurita T, et al: Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate 67: 162-171, 2007. (Pubitemid 46185319)
7. Gout PW, Kang YJ, Buckley DJ, et al: Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells. Leukemia 11: 1329-1337, 1997. (Pubitemid 27387312)
8. Bannai S and Tateishi N: Role of membrane transport in metabolism and function of glutathione in mammals. J Membr Biol 89: 1-8, 1986. (Pubitemid 16180559)
9. Verrey F, Closs EI, Wagner CA, et al: CATs and HATs: the SLC7 family of amino acid transporters. Pfugers Arch 447: 532-542, 2004. (Pubitemid 38258215)
10. - cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol 215: 593-602, 2008. (Pubitemid 351632680)
11. Lyons SA, Chung WJ, Weaver AK, et al: Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 67: 9463-9471, 2007. (Pubitemid 47535936)
12. - and thereby promotes tumor growth. Cancer Cell 19: 387-400, 2011.
13. Okabe H, Beppu T, Ueda M, et al: Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts. Int J Cancer: February 15, 2012 (Epub ahead of print).
14. Fu LY, Jia HL, Dong QZ, et al: Suitable reference genes for real-time PCR in human HBV-related hepatocellular carcinoma with different clinical prognoses. BMC Cancer 9: 49, 2009.
15. Guo W, Zhao Y, Zhang Z, et al: Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma. Cancer Lett 312: 55-61, 2011.
16. Lastro M, Kourtidis A, Farley K and Conklin DS: xCT expression reduces the early cell cycle requirement for calcium signaling. Cell Signal 20: 390-399, 2008.
17. Huang Y, Dai Z, Barbacioru C and Sadee W: Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res 65: 7446-7454, 2005. (Pubitemid 41161279)
18. Okuno S, Sato H, Kuriyama-Matsumura K, et al: Role of cystine transport in intracellular glutathione level and cisplatin resistance in human ovarian cancer cell lines. Br J Cancer 88: 951-956, 2003. (Pubitemid 36520886)
19. Bannai S: Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem 261: 2256-2263, 1986. (Pubitemid 17205155)
20. Eck HP and Droge W: Influence of the extracellular glutamate concentration on the intracellular cyst(e)ine concentration in macrophages and on the capacity to release cysteine. Biol Chem Hoppe Seyler 370: 109-113, 1989. (Pubitemid 19068080)
21. Rimaniol AC, Mialocq P, Clayette P, et al: Role of glutamate transporters in the regulation of glutathione levels in human macrophages. Am J Physiol Cell Physiol 281: C1964-C1970, 2001.
22. Ganapathy V, Thangaraju M and Prasad PD: Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 121: 29-40, 2009.
23. Capell HA, Madhok R, Porter DR, et al: Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the doubleblind placebo-controlled MASCOT study. Ann Rheum Dis 66: 235-241, 2007. (Pubitemid 46226060)
24. Gout PW, Buckley AR, Simms CR and Bruchovsky N: Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)-cystine transporter: a new action for an old drug. Leukemia 15: 1633-1640, 2001. (Pubitemid 32994684)
25. Narang VS, Pauletti GM, Gout PW, et al: Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of doxorubicin. Chemotherapy 53: 210-217, 2007. (Pubitemid 46581995)